The Thing Everyone’s Doing

You know that moment when you realize everyone has suddenly started talking about the same obscure thing? That’s been the dopamine menu for the past few months. If you’ve somehow missed it, here’s the premise: you make a list of activities organized by how much effort they require and how much dopamine reward they deliver. Low effort, low reward activities in one column. High effort, high reward in another. The idea is that when your brain is fried and can’t make decisions, you pick something from the appropriate tier instead of doom-scrolling for two hours wondering what you should be doing.

The concept exploded on TikTok last year, and I mean exploded. We’re talking eight hundred million views under the #dopaminemenu hashtag by early 2025. That’s not hyperbole—that’s just where we are now. People were creating color-coded Notion templates, filming their dopamine menus, organizing them by season. It became a whole thing. A Notion survey showed that dopamine menu templates got downloaded over a million times in the last quarter of 2024 alone, making it basically the second most popular wellness template after habit trackers. Which tells you something about where we’re collectively at with decision-making.

Why This Actually Made Sense to Try

I have ADHD. I got diagnosed as an adult, which is common enough that it barely registers as interesting anymore—there are an estimated 366 million adults with ADHD globally now according to a recent Lancet Psychiatry ADHD prevalence meta-analysis. It’s not exactly niche anymore. One of the things nobody tells you about adult ADHD diagnosis is that suddenly all these small frustrations get a name. Like decision paralysis. Like the fact that choosing between forty different activities feels harder than actually doing any of them.

What made the dopamine menu interesting wasn’t that it was trendy, but that psychiatrists were actually backing it. Dr. Ned Hallowell, who literally wrote the book on ADHD (okay, he co-authored ADHD 2.0, but you know what I mean), called it “CBT in meme form” in an interview with ADDitude Magazine on dopamine menus. The concept aligns with established behavioral activation therapy, which meant this wasn’t just wellness theater. It was actual behavioral science wrapped in a TikTok bow. A survey from CHADD found that forty-four percent of adults tried some version of structured leisure planning after seeing it on social media, and sixty-one percent of those people reported less decision fatigue. Those are decent numbers. Decent enough that I thought: why not?

What I Actually Built

I made my dopamine menu on a Sunday morning like a reasonable person and then spent way too much time color-coding it. Low effort activities included things like scrolling Reddit for exactly fifteen minutes, making tea, taking a bath, listening to music. Medium effort stuff was reading a book chapter, calling a friend, going for a walk. High effort activities were things like writing, reorganizing a room, cooking an actual meal. I was very proud of this menu. It felt organized. It felt like I had my life sorted. I printed it out and everything.

For about three weeks, I actually used it. Every time I felt stuck, I’d look at my menu and pick something instead of melting into decision paralysis. It worked, too. I wasn’t wasting two hours figuring out what to do with myself. I was just doing something. The decision fatigue was noticeably lower. I felt more productive, less anxious. This was vindication. The internet had provided a solution and it had solved something.

Where It Got Weird

Then I noticed something embarrassing. The activities I kept reaching for were all the low effort ones. Every single time. Never the medium. Basically never the high effort stuff. I would look at “high effort” and think about it the same way you think about doing your taxes, something you acknowledge exists but will definitely do later. So I paid attention. I started tracking which activities I actually picked, and it was almost comical. Bath, tea, Reddit scroll, music, repeat.

And here’s the thing that stuck with me: that wasn’t a bug in the system. That was exactly what the system was supposed to do. I was supposed to meet myself where I was at. If my brain couldn’t handle high effort that day, fine. Pick something else. That’s the whole point of the dopamine menu, judgment-free activity selection.

But I kept using it for eight weeks because something about the pattern bothered me. And slowly, something became unavoidable. The embarrassing part. I wasn’t actually struggling with decision fatigue. Not really. Not most days. What I was actually doing was giving myself permission to do only low-effort things and calling it productive self-care. The menu became my excuse. I was using a legitimate tool as a prop in a story I was telling myself about why I wasn’t doing the things I actually wanted to be doing.

What Changed After I Admitted This

The dopamine menu wasn’t wrong. It’s a genuinely useful tool and I think it’s genuinely helpful for people with actual executive dysfunction. But for me, it became a way to avoid confronting the real issue, which was that I’d gotten comfortable with doing easy things and I was scared to push myself back into harder things. That’s not a dopamine problem. That’s a motivation problem. Which feels like a different thing entirely.

So I stopped using the menu as my script and started using it more honestly. I’d check it when I was truly stuck, but mostly I tried to notice when I was reaching for the low-effort column out of habit versus genuine need. And it turned out I could actually handle more medium and high effort things than I’d convinced myself I could. They were just scary because I’d gotten used to not doing them.

I think this is why I’m writing this out now. Because the viral dopamine menu is genuinely useful, and I don’t want to trash something that’s actually helping people. But there’s also value in admitting that sometimes tools work great until they become excuses. The embarrassing truth I discovered about myself was that I’m really good at that. At taking something helpful and turning it into a comfortable avoidance pattern. If you’re using a dopamine menu and you notice yourself only ever picking the easy column, maybe check in with yourself the same way I had to. Maybe you’re genuinely fried and need easy things. Or maybe, like me, you’ve just gotten good at talking yourself into staying small.

The Conversation I Wasn’t Expecting

So there I was, sitting on that crinkly paper in the exam room, getting the usual “your blood pressure looks good” speech, when my doctor casually asked if I’d been thinking about trying a GLP-1 medication. Not in a judgmental way. Just like she was asking if I’d tried the new coffee place downtown. I laughed a little because honestly, I wasn’t sure if she was serious. But she was.

This wasn’t some random suggestion. She’d been my doctor for six years and knew my history, my actual lifestyle habits, and what I’d already tried. She explained that the medical thinking around weight loss has shifted pretty dramatically, and she thought it might be worth a real conversation. The thing is, she was right. The approach to obesity treatment has fundamentally changed in ways I didn’t fully grasp until she walked me through the specifics.

Why Everyone’s Suddenly Talking About This

You notice it everywhere now. Your coworker mentions Ozempic at lunch. A celebrity does an interview about it. Someone’s TikTok is about their Zepbound experience. It’s not just casual chatter—this reflects a massive shift in how these drugs are being prescribed. According to recent health data, prescriptions for GLP-1 receptor agonists increased by more than 400% between 2022 and 2025. That’s not a small uptick. That’s a complete recalibration of the market.

The American Medical Association updated its official obesity treatment guidelines in 2025 to list GLP-1 medications as a first-line option, which matters. These drugs aren’t being tucked into the “last resort” category anymore. They’re up there with lifestyle modifications as legitimate, evidence-based treatment. When major medical organizations make that kind of pivot, it usually means something real has shifted in the research.

The sales numbers tell their own story too. Novo Nordisk reported that global Ozempic and Wegovy sales exceeded $25 billion combined in 2025. You don’t get those kinds of numbers from a niche product. You get them from something that’s genuinely changing how people approach their health, for better or worse, depending on how you look at it.

What The Research Actually Shows

My doctor pulled up some recent data, and this is where things got interesting. A major trial published in the New England Journal of Medicine obesity research showed that tirzepatide, which goes by the brand name Zepbound, produced an average weight loss of 22.5% of body weight over 72 weeks in adults with obesity. That’s not trivial. That’s meaningful, measurable results over a sustained period. I asked her what that translates to in real terms, and she said for someone at, say, 250 pounds, that would be around 56 pounds. We’re not talking about incremental change here.

But here’s what my doctor emphasized: these drugs work because of how they interact with your hunger signals and your blood sugar regulation. They’re not stimulants that trick your body into burning more calories. They actually change how your brain perceives hunger and fullness. That’s why the weight loss is so consistent in the trials, she explained. You’re not white-knuckling your way through a diet. You’re actually eating less because your body is sending different signals.

The Part Nobody’s Really Talking About: Who It’s Actually For

This is where my doctor’s recommendation started to feel personalized instead of generic. She wasn’t suggesting I take this because I’m overweight and should be thinner. She was suggesting it because I have specific health markers—slightly elevated triglycerides, prediabetic glucose levels, a family history of type 2 diabetes—that would benefit from the metabolic effects of these medications. The weight loss is almost secondary to managing these underlying risks.

She also pointed out something I hadn’t considered: I’ve been trying to lose weight through diet and exercise modifications for years with limited success. That’s not a character flaw. That’s potentially a metabolic reality that these drugs actually address. Some people have a harder time with weight management not because they’re lazy or undisciplined, but because their body chemistry makes it structurally more difficult. These medications can help rebalance that.

Affordability came up too, and it’s worth being honest about because it’s a real barrier for a lot of people. According to the KFF GLP-1 medication tracking poll, about 1 in 8 American adults has taken a GLP-1 medication at some point, but 43% cited cost as the primary reason they stopped. My doctor was upfront that insurance coverage varies wildly depending on your plan, and we’d need to check my specific coverage before making any decisions.

Where I’m Landing on This

I’m not jumping into this immediately, but I’m also not dismissing it anymore. What shifted for me was understanding that this isn’t about vanity or taking a shortcut. It’s about using a medical tool that’s been thoroughly researched and officially integrated into obesity treatment guidelines because it actually works for certain people in certain situations. That’s the friend-over-coffee version of what my doctor explained: if you have metabolic markers that would benefit from it, and you’ve struggled with traditional approaches, this might be worth exploring with your doctor.

The key word there is “your doctor.” This isn’t a thing to decide based on someone’s Instagram post or what you overheard at the gym. It requires an actual conversation about your specific health history, your goals, what you’ve already tried, and what your insurance situation looks like. My doctor made that clear, and I appreciated it because it cut through all the noise.

If you’ve been wondering about this like I was, the real move is scheduling that conversation. Not because you should definitely take these drugs, but because the evidence has changed enough that it’s worth understanding what it actually says and what it might mean for you specifically.

The Conversation I Wasn’t Planning to Have

My annual physical was scheduled for a Tuesday morning in January. I showed up with the usual checklist: blood pressure check, cholesterol panel, the same questions about whether I’m flossing (I’m not, but I appreciate the optimism). What I didn’t expect was to spend twenty minutes discussing Ozempic.

My doctor brought it up. Not because she thought I needed it, but because, as she put it, “everyone’s asking about it now.” She wasn’t exaggerating. At this point, if you’re not personally considering GLP-1 medications, you probably know someone who is. Prescriptions for these drugs have increased by over 400 percent in just three years, which is the kind of statistic that makes you realize this isn’t some niche wellness trend anymore. It’s genuinely reshaping how people approach weight and health.

But here’s the thing about that conversation with my doctor: it didn’t give me the clean, definitive answer I wanted. It gave me something messier and, I think, more useful.

What the Numbers Actually Show (And Don’t)

Before we talked, I’d done that thing where you fall down a research rabbit hole at midnight. The clinical data is genuinely striking. A recent trial published in the New England Journal of Medicine obesity research showed that tirzepatide, marketed as Zepbound, produced an average weight loss of 22.5 percent of body weight over seventy-two weeks. That’s not marginal. That’s the kind of result that makes people pay attention.

The American Medical Association updated its obesity treatment guidelines in 2025 to officially list GLP-1 medications as a first-line treatment option, right alongside diet and exercise. That matters because it’s no longer positioned as a last resort. It’s mainstream medical protocol now.

My doctor pointed out these facts but also noted something the headlines don’t capture: these medications work best when combined with actual lifestyle changes. The trial data looks impressive, but those results came from people who were also modifying their diet and exercise habits. Nobody’s discovering some miraculous escape hatch here. The weight loss is real, but so is the work that comes with it.

The Accessibility Conversation Nobody Really Wants to Have

Then we got into the part that felt more real than any clinical trial. My doctor asked if I had insurance coverage. She asked what I’d heard about the cost. She mentioned that the global market for Ozempic and Wegovy has exceeded twenty-five billion dollars annually, which sounds like great news for innovation until you realize that amount of money exists precisely because most people can’t actually afford these drugs.

According to a recent KFF GLP-1 medication tracking poll, about one in eight American adults have tried a GLP-1 medication at some point. That sounds like a lot until you look at the second number: forty-three percent of people who’ve used these drugs cite affordability as the reason they stopped. The medications work. People can’t afford to keep taking them.

My doctor was honest about this. She said she has patients on these medications who do incredibly well with them. She also has patients who scraped together enough for a few months and then had to stop. Patients whose insurance covers it without question and patients whose insurance denies it categorically. The clinical efficacy is consistent. The human experience is all over the map.

What I Actually Walked Away With

Here’s what my doctor and I landed on: if someone is struggling with weight management and has tried other approaches, GLP-1 medications are a legitimate tool worth discussing with a physician. That’s not the same as saying everyone should be on them. It’s not saying they’re a miracle. It’s saying they’re real and they work for some people in specific circumstances.

But she also said something I keep thinking about. She said, “The question isn’t whether this medication works. The question is whether it works for you, for your life, in a way that’s sustainable and affordable and fits into whatever else you’re managing.” That’s a less sexy answer than you get from the headlines, but it’s the one that actually matters when you’re the one making the decision.

We didn’t end up deciding anything definitive, which is precisely the honest place to end up. I’m not on a GLP-1 medication. I haven’t ruled them out forever either. I’m sitting with the information, turning it over, considering it. My doctor is sitting with me in that space rather than pushing toward a conclusion.

Still Figuring It Out

The truth is that we’re all in a kind of collective experimental phase with these medications. They’re real. They work. They’re expensive. They’re becoming normalized. All of that is true at the same time. The data will keep changing. Access will hopefully improve. Our understanding of how they fit into health and wellness will keep shifting too.

If you’re considering GLP-1 medications or just curious about them, I’d genuinely encourage you to have this conversation with your own doctor rather than pulling your understanding from social media or celebrity interviews. Come with your own specific circumstances. Ask about cost. Ask about what happens if you stop taking it. Ask whether it actually fits your life, not just your weight loss goals. The answers you get will probably be as complicated as mine were, and that’s exactly how they should be.

The Thing About Having Numbers You Can’t Unsee

I bought the Oura Ring 4 back in November, right when everyone was posting their holiday shopping hauls and pretending they were finally going to get serious about their health. You know the energy. I told myself it was just curiosity. I had a friend who wouldn’t shut up about their ring, and I figured it was worth the $349 to satisfy my mild obsession with data and mild obsession with pretending I’m doing something productive about my sleep. What I didn’t anticipate was how aggressively a small piece of titanium on my finger would become a mirror I couldn’t avoid looking into every morning.

The Oura Ring 4 arrived with all the minimalist packaging that makes expensive things feel both thoughtful and slightly ridiculous. I charged it, downloaded the app, and started collecting data. The ring tracks heart rate variability, sleep stages, body temperature, respiratory rate, and movement. The newer model added cardiovascular age estimation and a resilience score that supposedly measures how well your body recovers from stress, both the physical kind and the invisible emotional kind that we all pretend isn’t destroying us. Within two weeks, I had enough data to make myself deeply uncomfortable.

The Readiness Score Became My Daily Accountability Partner

Here’s where it gets honest: I didn’t want a daily accountability partner. I wanted a ring that would tell me I was fine. Instead, I got a Readiness Score that appeared every morning and quietly suggested otherwise. According to Oura’s research, users who actually paid attention to this score and engaged with it daily averaged 23 more minutes of sleep per night after 90 days compared to people like my former self, who glanced at the data once and then scrolled through Instagram instead.

The first month, I watched my Readiness Score hover between 65 and 75. Not terrible. Not great. The kind of score that made me feel vaguely guilty without being catastrophic enough to actually change anything. I’d see it on my wrist while making coffee and think, “Yeah, I’m pretty tired, that checks out.” And then I’d do nothing about it. The ring was just confirming what I already knew, which felt pointless until I realized the real problem: I’d known for years that I wasn’t sleeping well, and I’d done nothing about that either. The ring didn’t create the problem. It just made ignoring it harder.

Then I started actually looking at the data. The ring showed me that my sleep stage distribution was completely off. Too little time in deep sleep and REM. My body wasn’t recovering properly. My heart rate variability suggested I was chronically stressed. The resilience score tracked my emotional recovery on the mornings after difficult days, and the picture wasn’t pretty. I couldn’t explain it away anymore. I couldn’t blame it on one bad night or seasonal variation. This was a pattern.

The Hard Truth About Sleep Data in America

I looked up some statistics because I do that when I’m feeling bad about myself. According to the CDC, one in three American adults regularly gets less than the recommended seven hours of sleep. The number hasn’t budged since 2016. Not one inch. Meanwhile, the wellness industry has exploded. We’ve got meditation apps, sleep supplements, blackout curtains, smart mattresses, white noise machines, and now rings that monitor everything. And yet. We’re still not sleeping.

I sat with this fact for a while. Here I was, spending money on a high-tech ring to measure a problem that everyone knows exists and nobody’s solving. CDC Sleep and Sleep Disorders Data shows the problem is staying the same despite a decade of wellness obsession. That’s not a problem with monitoring. That’s a problem with the way we live.

But here’s where I’m probably wrong about all of this. Or at least, not entirely right. The ring did something unexpected. It validated what I was experiencing. When Oura tested the Ring 4 against polysomnography, a legitimate medical sleep study, it achieved 79% accuracy in identifying sleep stages. That’s the highest accuracy of any consumer device tested. So when my ring told me I was getting fragmented sleep and insufficient deep sleep, it wasn’t guessing. It was probably right. That accuracy changed how seriously I took the data.

When Expensive Technology Meets Ordinary Human Resistance

Let me be clear about something: dropping $349 on a ring plus $5.99 a month for full data access because I needed motivation to sleep better is objectively ridiculous. I could have solved this with a calendar and some self-discipline. There’s been significant debate in online communities about whether the subscription paywall is worth it, and honestly, those people have a point. I paid for convenience and validation when what I actually needed was to stop staying up until 1 AM on my phone.

But the ring did something counterintuitive. Instead of letting me optimize my way out of the problem, it forced me to confront the real variables. The data showed me that my sleep improved most dramatically when I did three boring things: went to bed at the same time every night, stopped working two hours before bed, and put my phone in another room after dinner. None of this was new information. Health experts have been saying these things forever. What was new was having my own data show me that these boring habits worked better than any supplement or technology hack. The ring wasn’t solving the problem. I was solving the problem. The ring was just showing me the proof.

So What Changed, Actually

Six months in, my sleep looks different. My Readiness Score averages 78 now. My deep sleep is up. My REM sleep is more consistent. My heart rate variability has improved enough that the resilience score stays higher even on stressful days. I’m getting roughly 25 minutes more sleep per night than I was before, which lines up exactly with Oura’s research about what happens when you actually engage with the data.

But here’s the thing I’ve been turning over in my head: I don’t know if this improvement is because of the ring, or because I finally got tired enough of seeing the data to do something about it. Probably both. The ring was the permission structure. Sometimes we don’t change because we don’t have a good enough reason. Sometimes we need the data to make it real. Sometimes we need a expensive piece of technology on our finger to force us to admit that we’ve been choosing poorly every single night for years.

The uncomfortable truth the ring made me confront wasn’t that I was sleeping badly. It was that I knew how to sleep better and I just wasn’t doing it. That’s the harder conversation. Not with the device. With myself. If you’re thinking about getting one, that’s the real question to ask: are you ready to actually listen to what it tells you, or do you just want permission to keep doing what you’re already doing? Oura Ring 4 Official Features Overview has all the specs. But the specs aren’t the interesting part. You’re the interesting part. What would actually have to change?